Dashenlin

China's First Oral COVID-19 Antiviral Medicine in Dispute

An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.

Qiming-backed Biotech Insilico Medicine Completes Series D+ Financing Round

Insilico Medicine, the AI-powered biotech, aims to extend its services to all areas of life sciences with the newly added supporter from Saudi Arabia.

Aesthetic Medicine Company Tian Shi Wei Nets Tens of Millions of RMB in Series A Round

Soluble microneedle technology has received wide attention from the industry recently and is expected to be commercialized in aesthetic medicine. Tian Shi Wei gained capital preference for its R&D, mass production and quality control capabilities.

15 Companies to Watch in July 2022 - Healthcare

Editor's note: We at EqualOcean tracked the major funding rounds or industry events that took place in China's healthcare space in July 2022. And the following is a list of deals that we have selected for you, based on a number of criteria including the funding amount, the financial backers, and the segments in which the startups operate.

Grand Pharmaceutical Group Invest EUR 15 Mn in Dutch MedTech Xeltis

​Founded in 2006, Grand Pharmaceutical has developed a polymer-based restorative device for cardiovascular treatment. The restorative devices comprise heart valves and small diameter blood vessels for coronary artery bypass graft (CABG) surgery and for hemodialysis vascular access.